Acid Reflux

Disease

Disease Profile

Acid reflux (gastroesophageal reflux) occurs when stomach contents flow back into the esophagus and may cause heartburn. Gastroesophageal reflux disease (GERD) is the more severe, long-lasting form in which reflux causes bothersome recurrent symptoms or complications over time.

Category
Gastrointestinal disease
Prevalence
About 20% of people in the United States have GERD.
ICD Codes
  • K21
  • K21.0
  • K21.9

Related News

Bunnie Xo Reveals Suicidal Thoughts While Taking GLP-1 Weight-Loss Medication

Bunnie Xo, wife of country star Jelly Roll, revealed she experienced suicidal thoughts while taking semaglutide, describing December 2025 as "one of the darkest times of my life." She emphasized the importance of discussing mental health side effects of weight-loss medications and encouraged others facing similar struggles to seek help.

Related Clinical Trials

NCT ID Title Status Phase
NCT06241183

Famotidine and Antacids for Treatment of Dyspepsia

RECRUITING PHASE4
NCT04883567

The Use of AI to Improve Quality of OGD

UNKNOWN
NCT03516188

Efficacy of Gaviscon-Advance® in Suppressing Post-supper Acid-pocket and Night-time Acid-reflux in Obese Participants

COMPLETED PHASE2/PHASE3
NCT02749071

An Investigation of the EndoStim® Lower Esophageal Sphincter (LES) Stimulation System for the Treatment of Reflux

TERMINATED NA
NCT02700087

In Infants With Laryngomalacia, Does Acid-Blocking Medication Improve Respiratory Symptoms?

WITHDRAWN NA
NCT02226484

Can Quercetin Increase Claudin-4 and Improve Esophageal Barrier Function in GERD?

COMPLETED PHASE1
NCT01710995

A Three-Period Study to Investigate the Relative Bioavailability and Pharmacodynamic Profiles of a Zegerid 20mg Capsule, Zegerid 20mg Powder for Oral Suspension and Losec 20mg Capsule in Healthy Adult Volunteers Under Fasting Conditions

COMPLETED PHASE1
NCT01705275

A Study to Investigate the Effect of ONO-8539 on Acid-Induced Oesophageal Hypersensitivity in Healthy Volunteers

COMPLETED PHASE1